对间歇性肺病的临床研究取得了进展
Xiao-Lian Zhou1, Xiao-Bo Hu1, Yong-Sheng Wang1
1Department of Pulmonary and Critical Care Medicine, West China School of Medicine, Sichuan University, Sichuan University affiliated Chengdu Second People's Hospital, Chengdu Second People's Hospital, Chengdu, Sichuan, China.
Frontiers in medicine
|December 22, 2025
概括
本综述涵盖了间歇性肺病 (ILD) 的最新进展,重点关注病变发生,诊断和新型治疗方法,如精准医学和肺纤维化细胞治疗.
科学领域:
- 肺部病理学 肺部病理学
- 纤维化肺部疾病 纤维化肺部疾病
- 翻译医学是一种翻译医学.
背景情况:
- 间歇性肺病 (ILD) 是一组复杂的肺部疾病,发病率不断上升.
- 了解ILD的发病因子,包括信号通路和细胞损伤,对于开发有效的疗法至关重要.
研究的目的:
- 审查在ILD领域的尖端研究.
- 突出对病变发生,诊断进步和创新的治疗策略的新见解.
主要方法:
- 对最近关于ILD的研究进行文献综述.
- 在肺纤维化中探索关键信号通路 (例如TGF-β,Wnt/β-catenin).
- 对用于诊断和监测的新生物标志物的分析.
- 检查新兴治疗方法,包括药物试验,精准医学和再生疗法.
主要成果:
- 确定了TGF-β和Wnt/β-catenin通路在纤维化中的关键作用.
- 新的生物标志物显示出对ILD诊断和监测的前景.
- 新兴的治疗策略,如精密医学和细胞疗法正在推进.
结论:
- 本综述为ILD临床实践提供了最新的理论基础和治疗理念.
- 了解病原,诊断和治疗方面的进展为管理ILD提供了新的希望.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
274
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
274
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K


